Publication Name	World Journal of Gastroenterology
Manuscript ID	6150
Country	Italy

Received	2013-10-06 17:32
Peer-Review Started	2013-10-07 10:54
To Make the First Decision	2013-12-16 17:38
Return for Revision	2013-12-17 19:24
Revised
Second Decision	2014-01-15 20:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-01-15 20:28
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-03-11 09:08
Publish the Manuscript Online	2014-03-27 12:04

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Venous thromboembolism in patients with inflammatory bowel disease: Focus on prevention and treatment
Manuscript Source	Invited Manuscript
All Author List	Alfredo Papa, Viviana Gerardi, Manuela Marzo, Carla Felice, Gian Lodovico Rapaccini and Antonio Gasbarrini
Funding Agency and Grant Number
Corresponding Author	Alfredo Papa, MD, Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Via G. Moscati 31-33, 00168 Rome, Italy. apapa@rm.unicatt.it
Key Words	Inflammatory bowel disease; Venous thromboembolism; Thromboembolic prophylaxis; Anticoagulants; Unfractionated heparin; Low molecular weight heparin
Core Tip	Inflammatory bowel diseases (IBD) patients have an increased risk of venous thromboembolism (VTE) that represents a significant cause of morbidity and mortality. The prevention of VTE involves the correction of modifiable risk factors, such as: disease activity, vitamin deficiency, dehydration and prolonged immobilization. Essential is also the role of mechanical and pharmacological prophylaxis. However, thromboprophylaxis in IBD patients, although guideline-recommended is still poorly implemented because of concerns about its safety and, over all, the lack of awareness of the magnitude of thrombotic risk in these patients. Further efforts are required to increase the rate of pharmacological prevention of VTE in IBD so to avoid some preventable morbidity and mortality.
Publish Date	2014-03-27 12:04
Citation	Papa A, Gerardi V, Marzo M, Felice C, Rapaccini GL, Gasbarrini A. Venous thromboembolism in patients with inflammatory bowel disease: Focus on prevention and treatment. World J Gastroenterol 2014; 20(12): 3173-3179
URL	http://www.wjgnet.com/1007-9327/full/v20/i12/3173.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i12.3173

Full Article (PDF)	WJG-20-3173.pdf
Full Article (Word)	WJG-20-3173.doc
Manuscript File	6150-Review.docx
Answering Reviewers	6150-Answering Reviewers.pdf
Copyright License Agreement	6150-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	Editing_Certificate_20131005020527.pdf
Peer-review Report	6150-Peer review(s).pdf
Scientific Editor Work List	6150-Scientific editor work list.doc